Aprea Therapeutics
APRE
#11030
Rank
โ‚น0.55 B
Marketcap
โ‚น39.09
Share price
-5.41%
Change (1 day)
-62.94%
Change (1 year)

EPS for Aprea Therapeutics (APRE)

EPS in 2026 (TTM): -โ‚น97.69

According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น101.44. In 2025 the company made an earnings per share (EPS) of -โ‚น185.97 an increase over its 2024 EPS that were of -โ‚น223.54.

EPS history for Aprea Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น97.69-47.47%
2025-โ‚น185.97-16.81%
2024-โ‚น223.54
2022-โ‚น9,130177.74%
2021-โ‚น3,287-31.1%
2020-โ‚น4,77170.91%
2019-โ‚น2,792

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amedisys
AMED
โ‚น245.14-341.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
โ‚น141.82-239.81%๐Ÿ‡บ๐Ÿ‡ธ USA